Insider trades

See Tai Sandi, Chief Officer of Lexeo Therapeutics LXEO, has filed 0 purchases and 6 sales on the open market. Over the past 12 months that comes to a net sale of $38.4K. The latest trade was on 25/11/18.

See Tai Sandi

Chief Development Officer
First filing
25/01/10
Trades
10 trades
Buys / sales
0 / 6
12-month net buying
−$38.4K
Last trade
25/11/18

Trading activity

Transactions

Trade type
Open-market sale25/11/1825/11/20386 sh$9.27$3,578.22−0.6%
LXEO
Open-market sale25/10/1725/10/173,888 sh2 trades$8.95avg.$34,786−5.6%
Open-market sale25/08/1825/08/20382 sh$4.67$1,783.94−0.6%
Open-market sale25/05/1625/05/20367 sh$2.77$1,016.59−0.6%
Open-market sale25/02/1925/02/211,486 sh$4.41$6,553.26−2.7%